Literature DB >> 11714852

PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins.

D Lindén1, M Alsterholm, H Wennbo, J Oscarsson.   

Abstract

This study investigates the importance of peroxisome proliferator activated receptor alpha (PPARalpha) for serum apolipoprotein B (apoB) levels and hepatic secretion of apoB-containing lipoproteins. Total serum apoB and VLDL-apoB levels were higher in female PPARalpha-null mice compared with female wild-type mice, but no difference was seen in male mice. Furthermore, hepatic triglyceride secretion rate, determined in vivo after Triton WR1339 injection, was 2.4-fold higher in female PPARalpha-null mice compared with female wild-type mice, but no difference was observed in male mice. However, when fed a high fat diet, male PPARalpha-null mice displayed 2-fold higher serum levels of apoB and LDL cholesterol compared with male wild-type mice, but triglyceride levels were not affected. Hepatic LDL receptor protein levels were not influenced by PPARalpha deficiency, gender, or the fat diet. Hepatocyte cultures from female PPARalpha-null mice (cultured for 4 days in serum free medium) showed 2-fold higher total apoB secretion and increased secretion of apoB-48 VLDL, as well as 2.7-fold larger accumulation of VLDL-triglycerides in the medium compared with wild-type cultures. In conclusion, PPARalpha-deficient female mice, but not males, display high serum apoB associated with VLDL and increased hepatic triglyceride secretion. Moreover, male PPARalpha-null mice show increased susceptibility to high fat diet in terms of serum apoB levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714852

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  19 in total

1.  Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.

Authors:  Silvia Bijland; Elsbet J Pieterman; Annemarie C E Maas; José W A van der Hoorn; Marjan J van Erk; Jan B van Klinken; Louis M Havekes; Ko Willems van Dijk; Hans M G Princen; Patrick C N Rensen
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

2.  Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats.

Authors:  Ana Soria; Maria del Carmen González; Hubert Vidal; Emilio Herrera; Carlos Bocos
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

3.  Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.

Authors:  Zollie A Yavarow; Hye-Ri Kang; Lauren R Waskowicz; Boon-Huat Bay; Sarah P Young; Paul M Yen; Dwight D Koeberl
Journal:  Hum Mol Genet       Date:  2020-01-15       Impact factor: 6.150

4.  Olive Leaf Extract Elevates Hepatic PPAR α mRNA Expression and Improves Serum Lipid Profiles in Ovariectomized Rats.

Authors:  Leena Yoon; Ya-Nan Liu; Hyunjin Park; Hyun-Sook Kim
Journal:  J Med Food       Date:  2015-02-25       Impact factor: 2.786

5.  PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression.

Authors:  Vijay R More; Christopher R Campos; Rebecca A Evans; Keith D Oliver; Gary Ny Chan; David S Miller; Ronald E Cannon
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  ILRUN, a Human Plasma Lipid GWAS Locus, Regulates Lipoprotein Metabolism in Mice.

Authors:  Xin Bi; Takashi Kuwano; Paul C Lee; John S Millar; Li Li; Yachen Shen; Raymond E Soccio; Nicholas J Hand; Daniel J Rader
Journal:  Circ Res       Date:  2020-09-11       Impact factor: 17.367

Review 7.  Fatty liver, insulin resistance, and dyslipidemia.

Authors:  Martin Adiels; Marja-Riitta Taskinen; Jan Borén
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

8.  Hypoxia-inducible lipid droplet-associated (HILPDA) is a novel peroxisome proliferator-activated receptor (PPAR) target involved in hepatic triglyceride secretion.

Authors:  Frits Mattijssen; Anastasia Georgiadi; Tresty Andasarie; Ewa Szalowska; Annika Zota; Anja Krones-Herzig; Christoph Heier; Dariusz Ratman; Karolien De Bosscher; Ling Qi; Rudolf Zechner; Stephan Herzig; Sander Kersten
Journal:  J Biol Chem       Date:  2014-05-29       Impact factor: 5.157

9.  Hepatic mitochondrial and ER stress induced by defective PPARα signaling in the pathogenesis of hepatic steatosis.

Authors:  Qiaozhu Su; Chris Baker; Patricia Christian; Mark Naples; Xuedong Tong; Kezhong Zhang; Miklos Santha; Khosrow Adeli
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-15       Impact factor: 4.310

10.  Hepatic lipid metabolism response to dietary fatty acids is differently modulated by PPARalpha in male and female mice.

Authors:  Anne Morise; Charles Thomas; Jean-François Landrier; Philippe Besnard; Dominique Hermier
Journal:  Eur J Nutr       Date:  2009-07-09       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.